Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Kunstfeld · SciRah

Researcher profile · Semantic Scholar

R. Kunstfeld

Share profile

R. Kunstfeld — researcher profile on SciRah

h-index: 27
Works: 70
Citations: 4,110

Most-cited papers

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
S. Hirakawa, S. Kodama, R. Kunstfeld, K. Kajiya +2 more
2005Journal of Experimental Medicine736 citations Open access
Semantic Scholar
Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia.
R. Kunstfeld, S. Hirakawa, Young-Kwon Hong, V. Schacht +9 more
2004Blood334 citations
Semantic Scholar
VEGF‐A promotes tissue repair‐associated lymphatic vessel formation via VEGFR‐2 and the α1β1 and α2β1 integrins
Young-Kwon Hong, B. Lange‐Asschenfeldt, P. Velasco, S. Hirakawa +5 more
2004304 citations
Semantic Scholar
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial.
N. Basset-Seguin, A. Hauschild, R. Kunstfeld, J. Grob +17 more
2017European Journal of Cancer275 citations Open access
Semantic Scholar
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.
N. Basset-Seguin, A. Hauschild, J. Grob, R. Kunstfeld +16 more
2015The Lancet Oncology230 citations Open access
Semantic Scholar
Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.
Jay W. Shin, Michael Min, Frédéric Larrieu-Lahargue, X. Canron +6 more
2005Molecular Biology of the Cell197 citations Open access
Semantic Scholar
Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial.
B. Dréno, R. Kunstfeld, A. Hauschild, S. Fosko +9 more
2017The Lancet Oncology170 citations
Semantic Scholar
VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins.
Young-Kwon Hong, B. Lange‐Asschenfeldt, P. Velasco, S. Hirakawa +5 more
2004The FASEB Journal162 citations
Semantic Scholar
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
M. Lacouture, B. Dréno, P. Ascierto, R. Dummer +11 more
2016The Oncologist154 citations Open access
Semantic Scholar
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model.
R. Kunstfeld, G. Wickenhauser, U. Michaelis, M. Teifel +4 more
2003Journal of Investigative Dermatology138 citations Open access
Semantic Scholar
MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents.
M. Funovics, B. Kapeller, C. Hoeller, Henry S. Su +3 more
2004Magnetic Resonance Imaging135 citations
Semantic Scholar
Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin.
L. Cueni, I. Hegyi, Jay W. Shin, Andrea Albinger‐Hegyi +4 more
2010American Journal of Pathology132 citations Open access
Semantic Scholar
Dimethylfumarate impairs melanoma growth and metastasis.
R. Loewe, Teresa Valero, S. Kremling, Barbara Pratscher +3 more
2006Cancer Research118 citations Open access
Semantic Scholar
Long term results after surgical basal cell carcinoma excision in the eyelid region
S. Pieh, A. Kuchar, P. Novak, R. Kunstfeld +2 more
1999British Journal of Ophthalmology94 citations Open access
Semantic Scholar
Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options
Laura Desch, R. Kunstfeld
2013Journal of Skin Cancer64 citations Open access
Semantic Scholar
Successful treatment of vulvar lichen sclerosus with topical tacrolimus.
R. Kunstfeld, R. Kirnbauer, G. Stingl, F. Karlhofer
2003Archives of Dermatology53 citations Open access
Semantic Scholar
Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
V. Paulitschke, R. Kunstfeld, T. Mohr, A. Slany +5 more
2009Journal of Proteome Research50 citations
Semantic Scholar
An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
Y. Noh, Kant M. Matsuda, Young-Kwon Hong, R. Kunstfeld +6 more
2003Journal of Investigative Dermatology50 citations Open access
Semantic Scholar
The hsp27kD heat shock protein and p38-MAPK signaling are required for regular epidermal differentiation.
C. Jonak, M. Mildner, G. Klosner, V. Paulitschke +4 more
2011Journal of dermatological science (Amsterdam)47 citations
Semantic Scholar
Reduction of lymphatic vessels in photodamaged human skin.
K. Kajiya, R. Kunstfeld, M. Detmar, Jin H. Chung
2007Journal of dermatological science (Amsterdam)45 citations Open access
Semantic Scholar
Intradermal Indocyanine Green for In Vivo Fluorescence Laser Scanning Microscopy of Human Skin: A Pilot Study
C. Jonak, H. Skvara, R. Kunstfeld, F. Trautinger +1 more
2011PLoS ONE36 citations Open access
Semantic Scholar
Proteome Analysis Identified the PPARγ Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction
V. Paulitschke, S. Gruber, E. Hofstätter, Verena J. Haudek-Prinz +7 more
2012PLoS ONE35 citations Open access
Semantic Scholar
Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma
N. Schicher, V. Paulitschke, Alexander Swoboda, R. Kunstfeld +4 more
2009Clinical Cancer Research35 citations Open access
Semantic Scholar
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
C. Dittrich, M. Kosty, S. Jezdic, D. Pyle +94 more
2016ESMO Open34 citations Open access
Semantic Scholar
Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
V. Paulitschke, W. Berger, P. Paulitschke, E. Hofstätter +11 more
2015Molecular Cancer Therapeutics32 citations
Semantic Scholar
3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.
V. Paulitschke, N. Schicher, T. Szekeres, W. Jäger +11 more
2010Journal of Investigative Dermatology32 citations Open access
Semantic Scholar
Proteomic identification of a marker signature for MAPKi resistance in melanoma
V. Paulitschke, O. Eichhoff, C. Gerner, P. Paulitschke +18 more
2019EMBO Journal27 citations Open access
Semantic Scholar
Emerging drugs and combination strategies for basal cell carcinoma
J. Dreier, R. Dummer, Lea Felderer, M. Nägeli +2 more
2014Expert Opinion on Emerging Drugs25 citations
Semantic Scholar
Functional Classification of Cellular Proteome Profiles Support the Identification of Drug Resistance Signatures in Melanoma Cells
V. Paulitschke, Verena J. Haudek-Prinz, J. Griss, W. Berger +4 more
2013Journal of Proteome Research24 citations Open access
Semantic Scholar
Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
T. Brodowicz, D. Kandioler, S. Tomek, C. Ludwig +7 more
2001British Journal of Cancer24 citations Open access
Semantic Scholar
MCP-1 and MIP-1α are Most Efficient in Recruiting T Cells into the SkinIn Vivo
R. Kunstfeld, Sonja Lechleitner, K. Wolff, P. Petzelbauer
199824 citations Open access
Semantic Scholar
The Dermis‐Prelaminated Scapula Flap for Reconstructions of the Hard Palate and the Alveolar Ridge: A Clinical and Histologic Evaluation
I. Schlenz, K. Korak, R. Kunstfeld, K. Vinzenz +2 more
2001Plastic and Reconstructive Surgery22 citations
Semantic Scholar
Long‐term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials
H. Gollnick, T. Dirschka, R. Ostendorf, H. Kerl +1 more
2019Journal of the European Academy of Dermatology and Venereology21 citations Open access
Semantic Scholar
Impact of treatment breaks on vismodegib patient outcomes: Exploratory analysis of the STEVIE study.
R. Dummer, N. Basset-Seguin, J. Hansson, J. Grob +15 more
201521 citations
Semantic Scholar
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study
J. Hansson, K. Bartley, T. Karagiannis, J. Grob +17 more
2018EJD. European journal of dermatology20 citations
Semantic Scholar
Management of Merkel cell carcinoma of unknown primary origin: the Vienna Medical School experience
G. Haymerle, A. Fochtmann, R. Kunstfeld, J. Pammer +1 more
2015European Archives of Oto-Rhino-Laryngology20 citations
Semantic Scholar
Vismodegib, a Hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study interim analysis in 300 patients.
J. Grob, R. Kunstfeld, B. Dréno, T. Jouary +7 more
201317 citations
Semantic Scholar
Thrombospondin-2 overexpression in the skin of transgenic mice reduces the susceptibility to chemically-induced multistep skin carcinogenesis
R. Kunstfeld, T. Hawighorst, M. Streit, Young-Kwon Hong +3 more
2014Journal of dermatological science (Amsterdam)15 citations Open access
Semantic Scholar
Proteomic profiling of advanced melanoma patients to predict therapeutic response to anti-PD-1 therapy.
N. Zila, O. Eichhoff, Irene Steiner, T. Mohr +28 more
2023Clinical Cancer Research14 citations Open access
Semantic Scholar
A rare case of primary rhabdoid melanoma of the urinary bladder treated with ipilimumab, an anti-CTLA 4 monoclonal antibody
K. Schindler, N. Schicher, R. Kunstfeld, H. Pehamberger +4 more
2012Melanoma research14 citations
Semantic Scholar
Merkel cell carcinoma: Overall survival after open biopsy versus wide local excision
G. Haymerle, A. Fochtmann, R. Kunstfeld, J. Pammer +1 more
2016Head and Neck13 citations
Semantic Scholar
Proteome profiling of keratinocytes transforming to malignancy
V. Paulitschke, C. Gerner, E. Hofstätter, T. Mohr +3 more
2015Electrophoresis13 citations
Semantic Scholar
Secretome Proteomics, a Novel Tool for Biomarkers Discovery and for Guiding Biomodulatory Therapy Approaches
V. Paulitschke, R. Kunstfeld, C. Gerner
201013 citations
Semantic Scholar
A unique case of a benign disseminated angioproliferation combining features of Kaposi's sarcoma and diffuse dermal angioendotheliomatosis.
R. Kunstfeld, P. Petzelbauer
2001Journal of American Academy of Dermatology11 citations
Semantic Scholar
Smoothened inhibitors in the treatment of advanced basal cell carcinomas
R. Kunstfeld
2014Current Opinion in Oncology10 citations
Semantic Scholar
Vismodegib (VISMO), a hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study primary analysis in 1215 patients (pts).
J. Hansson, A. Hauschild, R. Kunstfeld, J. Grob +16 more
20169 citations
Semantic Scholar
The Prefabricated Scapula Flap Consists of Syngeneic Bone, Connective Tissue, and a Self‐Assembled Epithelial Coating
R. Kunstfeld, P. Petzelbauer, G. Wickenhauser, I. Schlenz +3 more
2001Plastic and Reconstructive Surgery9 citations
Semantic Scholar
Quality‐of‐life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient‐reported outcomes from the MIKIE study
D. Schadendorf, A. Hauschild, S. Fosko, D. Zloty +9 more
2020Journal of the European Academy of Dermatology and Venereology8 citations
Semantic Scholar
MIKIE: A randomized, double-blind, regimen-controlled, phase II, multicenter study to assess the efficacy and safety of two different vismodegib regimens in patients with multiple basal cell carcinomas.
R. Kunstfeld, A. Hauschild, D. Zloty, G. Rogers +4 more
20147 citations
Semantic Scholar
Mikie: A randomized, double-blinded, regimen-controlled, phase 2 study to assess the efficacy and safety of two different vismodegib (VISMO) regimens in patients (pts) with multiple basal cell carcinomas (BCCs).
G. Rogers, R. Kunstfeld, D. Schadendorf, A. Hauschild +8 more
20166 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Hauschild×11
Invite
A. Hauschild — researcher profile on SciRah
B. Dréno×11
Invite
B. Dréno — researcher profile on SciRah
H. Pehamberger×11
Invite
H. Pehamberger — researcher profile on SciRah
V. Paulitschke×10
Invite
V. Paulitschke — researcher profile on SciRah

×9

Invite

M. Detmar — researcher profile on SciRah

Invite

R. Dummer — researcher profile on SciRah

Invite

C. Gerner — researcher profile on SciRah

N. Basset-Seguin×7

Invite

N. Basset-Seguin — researcher profile on SciRah

Invite

J. Grob — researcher profile on SciRah

Young-Kwon Hong×6

Invite

Young-Kwon Hong — researcher profile on SciRah

Invite

L. Mortier — researcher profile on SciRah

Invite

P. Ascierto — researcher profile on SciRah